Inactive

The U.S. Army Medical Research Acquisition Activity (USAMRAA) is issuing this sources sought notice (SSN) on behalf of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) as a mean... The U.S. Army Medical Research Acquisition Activity (USAMRAA) is issuing this sources sought notice (SSN) on behalf of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) as a means of conducting market research to identify parties having an interest in and the resources to support the requirement for Anti-Carfentanil monoclonal antibody (mAb) for use in Non-Human Primates. Based on the responses to this sources sought notice, this requirement may be set-aside for small business (in full or in part) or procured through full and open competition. All small business set-aside categories will be considered. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions. ***PLEASE SEE THE ATTACHED SOURCES SOUGHT NOTICE***